Close Menu
  • News
  • Entertainment
  • Sports
  • World
  • Health
  • Lifetsyle
  • contact

Subscribe to Updates

Get the latest creative news from FooBar about art, design and business.

What's Hot

MICHAEL RUIZ: Resurfaced video appears to show NYC mayor arrested by NYPD group he is disbanding

November 20, 2026

Suspect in alleged rape of LSU student killed by car fights to keep mom’s warning texts out of December trial

November 20, 2026

Woman allegedly torments California family claiming to be toddler who vanished in 1984, refuses basic DNA test

November 20, 2026
Facebook X (Twitter) Instagram
Trending
  • MICHAEL RUIZ: Resurfaced video appears to show NYC mayor arrested by NYPD group he is disbanding
  • Suspect in alleged rape of LSU student killed by car fights to keep mom’s warning texts out of December trial
  • Woman allegedly torments California family claiming to be toddler who vanished in 1984, refuses basic DNA test
  • Fanatics Sportsbook Promo Code FOXNEWS: Claim $1000 in FanCash Betting on Tonight’s NBA Cup Slate
  • SJSU volleyball finishes near bottom of conference as Trump admin battle, coach allegations loom over program
  • Fox News AI Newsletter: AI platforms generated terror plans, feds find
  • Biden memoir draws fire for ‘denial’ as critics flag Gaza, racial-equity omissions
  • From panic rooms to private bowling alleys, Reddit reveals what only rich people have at home
Facebook X (Twitter) Instagram
NEW YORK TIMES POST
  • News
  • Entertainment
  • Sports
  • World
  • Health
  • Lifetsyle
  • contact
NEW YORK TIMES POST
Home»Health»Diagnostic test could flag which men need aggressive prostate cancer treatment and which don't
Health

Diagnostic test could flag which men need aggressive prostate cancer treatment and which don't

nytimespostBy nytimespostOctober 28, 2026No Comments
Facebook Twitter Pinterest LinkedIn WhatsApp Reddit Tumblr Email
Share
Facebook Twitter LinkedIn Pinterest Email


NEWYou can now listen to Fox News articles!

A new diagnostic test could improve the prostate cancer experience for millions of men.

Researchers at University College London (UCL) analyzed a tissue-based molecular test called Decipher to determine which men with high-risk prostate cancer were most likely to benefit from stronger treatment — and which might avoid unnecessary medication and side effects.

The analysis focused on abiraterone, a hormone therapy that was shown in the STAMPEDE clinical trial to cut the risk of death in half among men with high-risk, localized prostate cancer.

The findings were presented at the European Society for Medical Oncology (ESMO) Congress 2026 in Madrid, held Oct. 23–27.

JOE BIDEN SHARES HEALTH UPDATE AFTER PROSTATE CANCER DIAGNOSIS WHILE ISSUING WARNING TO OTHERS

Not every cancer is alike, and treating someone more aggressively than necessary could have “increased side effects and poorer quality of life,” noted a UCL news release.

Because prostate cancers differ at the molecular level, not every patient benefits from adding hormone therapy.

Male doctor and testicular cancer patient are discussing about testicular cancer test report

Adding a hormone therapy called abiraterone to standard treatment for men with high-risk, localized prostate cancer could cut the risk of death in half, the trial found.

To determine whether Decipher could help guide that decision, researchers examined test scores from more than 27,000 patients in real-world data and 401 men with non-metastatic prostate cancer who had participated in the STAMPEDE abiraterone trial.

PATIENTS REMAIN CANCER-FREE NEARLY 3 YEARS AFTER RECEIVING EXPERIMENTAL IMMUNOTHERAPY

Higher Decipher scores predicted worse outcomes, meaning the cancer is more likely to spread and additional treatment may be valuable. A low Decipher score suggested more intensive treatment may be unnecessary.

CLICK HERE TO DOWNLOAD THE FOX NEWS APP

Lead researcher Dr. Sarah Howlett of UCL Cancer Institute commented in a statement that for men with very high-risk prostate cancer, preventing spread of the disease is “critical.”

“Understanding who benefits most from additional treatment can make a meaningful difference,” she added.

man has IV put into arm by female nurse

A genomic test could help to personalize treatments for prostate cancer patients, the researchers suggested. (iStock)

The findings suggest that genomic testing could help tailor treatment, according to the researcher.

Men with high-risk prostate cancer and low Decipher scores may face a lower risk of spread and could avoid more intensive therapy, while those with high scores may be the strongest candidates for additional treatment.

Identifying the same pattern in both a large, real-world dataset and a randomized clinical trial strengthens the findings, Howlett noted.

CANCER WARNING SIGNS MAY APPEAR IN DNA YEARS BEFORE BLOOD TESTS DETECT TROUBLE

“But further validation in other datasets is needed before the test is used routinely to make these decisions,” she said.

Elai Davicioni, medical director of urology for Decipher test maker Veracyte, also commented, “We believe this growing evidence gives physicians a stronger reason to use Decipher before making decisions that can affect both cancer outcomes and patients’ quality of life.”

Doctor talking to a patient in a consultation at the office

Men with high-risk prostate cancer and low Decipher scores may face a lower risk of spread and could avoid more intensive therapy, while those with high scores may be the strongest candidates for additional treatment. (iStock)

Fox News senior medical analyst Dr. Marc Siegel, who was not involved in the study, also commented on the findings.

“Prostate cancer varies from person to person,” he said. “Medical science is increasingly aware that it is not one size fits all.”

Localized prostate cancer, which has not yet spread, may contain mutations that predict how aggressive the disease will be and indicate whether it could respond to targeted therapies, Siegel noted.

Man waiting for MRI scan

About one in eight American men will be diagnosed with prostate cancer in their lifetime, according to the American Cancer Society. (iStock)

Certain targeted therapies are being used more with widespread prostate cancer, according to the doctor, as they include “more powerful anti-androgens, which works not just on the testes, but on the adrenals as well.”

Hormone therapies have “significant side effects,” including fatigue, and “don’t always help,” he added.

TEST YOURSELF WITH OUR LATEST LIFESTYLE QUIZ

Siegel said the study’s strength was its combination of a randomized treatment group with Decipher testing, which helped identify in advance which patients were most likely to respond to intensive hormone therapy.

“This is the personalized, precise approach of the near future,” he said.

doctor-giving-consult

Many men, but not all with high-risk localized prostate cancer, will have a cancer recurrence after local therapy, according to Dr. Dahut. (Getty Images )

Dr. William Dahut, M.D., chief scientific officer at the American Cancer Society, noted that many men with high-risk localized prostate cancer will have a recurrence after local therapy.

“This study shows that by combining drugs that interfere with the male hormone testosterone with standard therapy, the risk of cancer recurrence decreases,” the Maryland-based doctor, who was not involved in the study, told Fox News Digital. 

CLICK HERE FOR MORE HEALTH STORIES

Traditionally, if a more intensive therapy benefits some patients, it is offered to all men — even though only a subset may actually benefit, according to Dahut.

“However, a diagnostic test can greatly improve the treatment experience for a patient by potentially only subjecting patients to more intensive therapies whose genomic test predicts the greatest risk of recurrence,” he said.

Dahut encouraged patients to speak with their doctors about intensive therapy to decrease the risk of cancer recurrence, as well as to ask about available genomic testing.

The doctor noted that since the study was conducted with a drug to block testosterone and the oral drug abiraterone, it’s “unclear whether the Decipher test would be as accurate with other possible combinations that a patient might receive.”

CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER

Prostate cancer is the second-leading cause of cancer death behind lung cancer, according to the American Cancer Society. About one in eight American men will be diagnosed with prostate cancer in their lifetime.

Angelica Stabile is a lifestyle reporter for Fox News Digital.

aggressive cancer cancer research Diagnostic don039t flag health lifestyle medical research medications men mens health Prostate prostate cancer Test treatment
Share. Facebook Twitter Pinterest LinkedIn Tumblr Telegram Email

Related Posts

Woman allegedly torments California family claiming to be toddler who vanished in 1984, refuses basic DNA test

November 20, 2026

Biden memoir draws fire for ‘denial’ as critics flag Gaza, racial-equity omissions

November 20, 2026

From panic rooms to private bowling alleys, Reddit reveals what only rich people have at home

November 20, 2026
Leave A Reply Cancel Reply

The Latest News
  • MICHAEL RUIZ: Resurfaced video appears to show NYC mayor arrested by NYPD group he is disbanding November 20, 2026
  • Suspect in alleged rape of LSU student killed by car fights to keep mom’s warning texts out of December trial November 20, 2026
  • Woman allegedly torments California family claiming to be toddler who vanished in 1984, refuses basic DNA test November 20, 2026
  • Fanatics Sportsbook Promo Code FOXNEWS: Claim $1000 in FanCash Betting on Tonight’s NBA Cup Slate November 20, 2026
  • SJSU volleyball finishes near bottom of conference as Trump admin battle, coach allegations loom over program November 20, 2026
  • Fox News AI Newsletter: AI platforms generated terror plans, feds find November 20, 2026
Top Posts

MICHAEL RUIZ: Resurfaced video appears to show NYC mayor arrested by NYPD group he is disbanding

November 20, 2026

Suspect in alleged rape of LSU student killed by car fights to keep mom’s warning texts out of December trial

November 20, 2026

Woman allegedly torments California family claiming to be toddler who vanished in 1984, refuses basic DNA test

November 20, 2026

Fanatics Sportsbook Promo Code FOXNEWS: Claim $1000 in FanCash Betting on Tonight’s NBA Cup Slate

November 20, 2026
Don't Miss
Sports

MICHAEL RUIZ: Resurfaced video appears to show NYC mayor arrested by NYPD group he is disbanding

By nytimespostNovember 20, 2026

NEWYou can now listen to Fox News articles! Years before New York City’s socialist Mayor…

Suspect in alleged rape of LSU student killed by car fights to keep mom’s warning texts out of December trial

November 20, 2026

Woman allegedly torments California family claiming to be toddler who vanished in 1984, refuses basic DNA test

November 20, 2026

Fanatics Sportsbook Promo Code FOXNEWS: Claim $1000 in FanCash Betting on Tonight’s NBA Cup Slate

November 20, 2026
Stay In Touch
  • Facebook
  • Twitter
  • Pinterest
  • Instagram
  • YouTube
  • Vimeo

Subscribe to Updates

Get the latest creative news from SmartMag about art & design.

NEW YORK TIMES POST

 

Categories
  • Business
  • Culture
  • Fashion
  • Food
  • Tech
  • Sports
  • Travel
  • Nature
Services
  • News
  • Entertainment
  • Sports
  • World
  • Health
  • Lifetsyle
  • contact
About Us

Email Us: info@nytimespost.com
Contact:

Facebook X (Twitter) Pinterest YouTube WhatsApp
Our Picks

MICHAEL RUIZ: Resurfaced video appears to show NYC mayor arrested by NYPD group he is disbanding

November 20, 2026

Suspect in alleged rape of LSU student killed by car fights to keep mom’s warning texts out of December trial

November 20, 2026

Woman allegedly torments California family claiming to be toddler who vanished in 1984, refuses basic DNA test

November 20, 2026
Most Popular

MICHAEL RUIZ: Resurfaced video appears to show NYC mayor arrested by NYPD group he is disbanding

November 20, 2026

Suspect in alleged rape of LSU student killed by car fights to keep mom’s warning texts out of December trial

November 20, 2026

Woman allegedly torments California family claiming to be toddler who vanished in 1984, refuses basic DNA test

November 20, 2026
© 2026 NY TIMES POST by NEW TORK TIMES POST.

Type above and press Enter to search. Press Esc to cancel.